Treatment of amyotrophic lateral sclerosis

Details for Australian Patent Application No. 2009318098 (hide)

Owner Northwestern University Cambria Pharmaceuticals, Inc.

Inventors Kirsch, Donald R.; Benmohamed, Radhia; Arvanites, Anthony C.; Morimoto, Richard I.; Chen, Tian; Silverman, Richard B.

Agent Davies Collison Cave

Pub. Number AU-A-2009318098

PCT Pub. Number WO2010/059241

Priority 61/116,571 20.11.08 US

Filing date 20 November 2009

Wipo publication date 27 May 2010

International Classifications

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 231/44 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059241 Priority application(s): WO2010/059241

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009318101-Method for reducing thrombocytopenia and thrombocytopenia-associated mortality

2009318085-Systems and methods for operating a plurality of wells through a single bore